Castle Creek Arbitrage’s LAVA Medtech Acquisition Corp. Warrants LVACW Stock Holding History

Castle Creek Arbitrage’s Portfolio LVACW Stock Details LVACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-300,000	Closed	-$22.5K	–	452
2023 Q1	$22.5K	Hold	300,000	–	–	﹤0.01%	283
2022 Q4	$1.53K	Buy	+300,000	New	+$14.8K	﹤0.01%	494

Castle Creek Arbitrage's LVACW Position: Q2 2023 in Review

Castle Creek Arbitrage sold out of LAVA Medtech Acquisition Corp. Warrants (LVACW) in Q2 2023, closing a stake of 300,000 shares — an estimated $22.5K sold.

Castle Creek Arbitrage first reported a position in LVACW in Q4 2022 and held it in 2 quarters. The position peaked at $22.5K in Q1 2023. 0 funds tracked by Wall St. Rank hold LVACW as of Q2 2023.

Castle Creek Arbitrage reported no remaining LAVA Medtech Acquisition Corp. Warrants position as of Q2 2023 after selling out during the quarter.
Castle Creek Arbitrage sold 300,000 LAVA Medtech Acquisition Corp. Warrants shares in Q2 2023, an estimated $22.5K.
Castle Creek Arbitrage first reported a position in LAVA Medtech Acquisition Corp. Warrants in Q4 2022 and held it in 2 quarters.
Castle Creek Arbitrage's LAVA Medtech Acquisition Corp. Warrants position peaked at $22.5K in Q1 2023.
0 funds tracked by Wall St. Rank held LAVA Medtech Acquisition Corp. Warrants as of Q2 2023.

Based on Castle Creek Arbitrage's 13F filing for Q2 2023, filed 14 Aug 2023.